Contact this trialFirst, we need to learn more about you.
KRAS G12C Inhibitor
BBO-8520 + Pembrolizumab for Lung Cancer
Recruiting1 awardPhase 1
Nashville, Tennessee
"This trial is testing a new drug called BBO-8520 to see if it is safe and well-tolerated in patients with advanced lung cancer. They will also be looking at how the drug
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service